CAMPUS CML – CHRONIC MYELOID LEUKEMIA

1. 1.Valentina Giai et al.. Chronic myeloid leukemia outcomes according to baseline risk and first-line treatment in real-world settings: Data from the Italian Network/CML Campus. Cancer . 2025 Jul 1;131(13):e35963. doi: 10.1002/cncr.35963.. 2025
   Articolo scientificoCancer . 2025 Jul 1;131(13):e35963. doi: 10.1002/cncr.35963.Cerca su Google Scholar
2. 2.Mario Tiribelli et al.. Determinants of frontline tyrosine kinase inhibitor choice for patients with chronic-phase chronic myeloid leukemia: A study from the Registro Italiano LMC and Campus CML. Cancer . 2023 Sep 1;129(17):2637-2644. doi: 10.1002/cncr.34923. Epub 2023 Jun 24.. 2023
   Articolo scientificoCancer . 2023 Sep 1;129(17):2637-2644. doi: 10.1002/cncr.34923. Epub 2023 Jun 24.Cerca su Google Scholar
3. 3.Alessandra Iurlo et al.. Treatment-Free Remission in Chronic Myeloid Leukemia Patients Treated With Low-Dose TKIs: A Feasible Option Also in the Real-Life. A Campus CML Study. Front Oncol . 2022 Mar 3:12:839915. doi: 10.3389/fonc.2022.839915. eCollection 2022.. 2022
   Articolo scientificoFront Oncol . 2022 Mar 3:12:839915. doi: 10.3389/fonc.2022.839915. eCollection 2022.Leggi il PDF gratuito
4. 4.Massimo Breccia et al.. COVID-19 infection in chronic myeloid leukaemia after one year of the pandemic in Italy. A Campus CML report. Br J Haematol . 2022 Feb;196(3):559-565. doi: 10.1111/bjh.17890. Epub 2021 Oct 11.. 2022
   Articolo scientificoBr J Haematol . 2022 Feb;196(3):559-565. doi: 10.1111/bjh.17890. Epub 2021 Oct 11.Cerca su Google Scholar

I link ai libri possono contenere un codice affiliato Amazon: in qualità di affiliato, ECM Finder potrebbe ricevere una commissione sugli acquisti idonei, senza alcun costo aggiuntivo per te. I link ai paper rimandano alla fonte scientifica (DOI, versione open-access o ricerca accademica).